Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 36

Results For "THA"

8516 News Found

Servier to acquire Edgewise muscular dystrophy business in $2.65 billion deal
News | June 03, 2026

Servier to acquire Edgewise muscular dystrophy business in $2.65 billion deal

The transaction includes an upfront payment of $1.55 billion, along with up to $1.1 billion in regulatory and commercial milestone payments


Cipla launches India's first sputum inflammometry lab in Mumbai
Healthcare | June 03, 2026

Cipla launches India's first sputum inflammometry lab in Mumbai

The facility sets a new benchmark in respiratory diagnostics


Virohan launches Rs. 2 crore scholarship to promote health education among women
Healthcare | June 03, 2026

Virohan launches Rs. 2 crore scholarship to promote health education among women

The initiative opens pathways for female students to pursue healthcare programs across 20+ top universities and colleges in India


Granules Pharmaceuticals receives USFDA EIR for Chantilly facility
News | June 03, 2026

Granules Pharmaceuticals receives USFDA EIR for Chantilly facility

This facility plays an important role in Granules’ global manufacturing and supply network


Marksans Pharma to acquire Netherlands-based QliniQ
News | June 02, 2026

Marksans Pharma to acquire Netherlands-based QliniQ

Acquisition provides direct access to the Dutch healthcare market, enhancing Marksans’ sales, distribution and market-access capabilities across regulated European markets


FDA okays AstraZeneca’s bladder cancer drug Imfinzi Plus BCG
Drug Approval | June 02, 2026

FDA okays AstraZeneca’s bladder cancer drug Imfinzi Plus BCG

First immunotherapy combination approved in the US for BCG-naïve high-risk NMIBC demonstrates a 32% reduction in the risk of disease recurrence, progression, or death


Scientists develop rapid nanosensor to detect gut health biomarker for IBD and diabetes
R&D | June 02, 2026

Scientists develop rapid nanosensor to detect gut health biomarker for IBD and diabetes

Novel fluorescent nanosensor enables real-time detection of indole-3-propionic acid (IPA), paving the way for faster gut health screening, point-of-care diagnostics, and wearable monitoring devices


Moderna and Merck’s mRNA cancer vax combo shows 5-year survival in melanoma trial
Clinical Trials | June 02, 2026

Moderna and Merck’s mRNA cancer vax combo shows 5-year survival in melanoma trial

An exploratory overall survival signal also leaned in favor of the combination, though the companies noted the result remains preliminary


CellCarta and Leica Biosystems expand push to streamline precision medicine development
News | June 02, 2026

CellCarta and Leica Biosystems expand push to streamline precision medicine development

The collaboration introduces a flexible, end-to-end CDx framework designed to adapt to shifting regulatory environments


BioNTech and Bristol Myers Squibb drug shows strong early signal in lung cancer trial
Clinical Trials | June 02, 2026

BioNTech and Bristol Myers Squibb drug shows strong early signal in lung cancer trial

The safety profile was described as manageable, though not without notable toxicities